Novo Integrated Sciences, Inc. (NVOS)

Market Cap	9.89M
Revenue (ttm)	13.66M
Net Income (ttm)	-12.08M
Shares Out	19.05M
EPS (ttm)	-0.64
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	442,829
Open	0.544
Previous Close	0.526
Day's Range	0.499 - 0.559
52-Week Range	0.416 - 5.380
Beta	-0.61
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 15, 2024

About NVOS

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline test...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Sep 22, 2017
• Employees: 127
• Stock Exchange: NASDAQ
• Ticker Symbol: NVOS

Financial Performance

In 2023, NVOS's revenue was $12.57 million, an increase of 7.11% compared to the previous year's $11.74 million. Losses were -$13.21 million, -59.77% less than in 2022.